Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo — taking Wegovy every 10 days instead of every seven is not how the medicine is licensed or prescribed. Wegovy (semaglutide) is a once-weekly injection, and the seven-day interval is built into both the clinical evidence and the UK prescribing guidance. Stretching doses to every 10 days changes the pharmacokinetics of the medicine in ways that have not been studied for weight management, and no clinical body recommends it. That said, the reasons people reach for this question are understandable (stock gaps, travel, cost, forgetting a dose mid-holiday) so this page works through what the evidence and guidance actually say, and what to do if a weekly schedule genuinely feels unworkable. These are prescription-only medicines, and any change to your dosing schedule is a decision for your prescriber, not one to make quietly at home.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide has a half-life of roughly seven days in the body, which is exactly why Wegovy was designed as a once-weekly injection. That half-life means a dose given every seven days produces relatively stable blood concentrations week to week, a plateau that gives both appetite suppression and tolerability. The STEP 1 trial, which underpins NICE's recommendation of semaglutide for weight management, enrolled participants on a strict weekly schedule; every efficacy and safety figure from that trial reflects seven-day dosing, not ten.
When you extend the gap to 10 days, you are spending three extra days at lower-than-intended drug levels. Over a 12-week titration, that is six missed "peak windows" compared with a weekly schedule. The body's exposure to the medicine drops; appetite suppression may lessen; and the gastrointestinal side effects that often ease with a steady blood level can resurface unpredictably when the next dose arrives. If you want to understand what taking Wegovy every 10 days instead of 7 actually means for your treatment, that question has been explored in more detail elsewhere on this site. Prescribers follow a licensed schedule because that schedule is the one that has been proven to work safely, not out of rigidity.
For a fuller picture of how semaglutide works and how the treatment pathway is structured, the Wegovy treatment overview covers this in more detail.
The occasional slight variation in timing (a day earlier because you are going away, a day late because you forgot) is different from deliberately spacing every injection at 10 days. The NHS patient information for semaglutide addresses missed doses specifically: if you remember within five days of your scheduled injection, take it as soon as you remember and then return to your usual weekly day. If more than five days have passed, skip that dose and carry on from your next scheduled date.
The key distinction is this: a genuine missed-dose situation has a defined rescue protocol. Taking wegovy every 10 days intentionally is something else entirely, it is an unofficial dose reduction with no clinical guidance behind it. Some people try this when stock is running low or when cost is a concern. Others hit it accidentally because life gets in the way around payday, a bank holiday, or a week away without a sharps bin. Whatever the reason, the answer is the same: contact your prescriber and explain what has happened, rather than settling into a 10-day rhythm. Your prescriber can advise on bridging, pause protocols, or whether an adjustment to your treatment plan is appropriate.
If you are curious about what happens with other non-standard intervals, the page on taking Wegovy every two weeks covers the fortnightly question in similar depth.
Not in the Wegovy weight-management context. Some prescribers managing different GLP-1 medicines in different clinical settings have explored extended intervals for tolerability reasons, but that is not a practice endorsed in Wegovy's UK Summary of Product Characteristics or in any published NICE or NHS guidance for weight loss. The argument that a lower dose delivered less often might reduce side effects sounds plausible, but it trades one problem for another: less consistent appetite suppression, less predictable tolerability, and a dosing pattern that has never been tested at maintenance doses in large populations. Some people also notice unexpected changes in their skin during treatment, and if that is a concern, the page on Wegovy and cellulite looks at what the evidence does and does not say.
There is a separate, related question about whether semaglutide can be taken every five days, which tends to come from people who have experienced a strong wearing-off effect towards the end of the week. Those questions involve different trade-offs; a discussion of whether shortening the interval makes sense covers that angle specifically. Either way, the core principle holds: changes to a licensed dosing schedule need a prescriber's involvement, not a self-directed experiment.
If the cost of maintaining a weekly schedule is a pressure, it is worth reading about how Wegovy is supplied and priced in the UK before drawing conclusions; the market has changed considerably since 2024 and the picture is more nuanced than many assume.
Talk to your prescriber. That sounds like a non-answer, but it is genuinely the most useful thing on this page. A prescriber can explore whether the difficulty is practical (injection anxiety, travel schedules, supply), financial, or related to side effects that are making the weekly dose feel daunting. Each of those has a different solution. Injection anxiety can often be helped by technique support or by switching injection site. Supply gaps have workarounds. Side-effect burden might mean slowing the titration pace or staying at a lower dose for longer, both of which are within the licensed framework. Ongoing difficulty tolerating the weekly schedule may even prompt a conversation about whether a different treatment approach would suit better.
At nume, every repeat order goes through a clinical re-review before it is dispensed. That means if you flag a timing problem to our team, there is a real prescriber on the other end reading it, not an automated response. If you have not yet started treatment and are weighing up whether a weekly injection is realistic for you, our prescribers can discuss this as part of your initial consultation, which is free and reviewed the same day. Semaglutide and tirzepatide both involve a personal conversation about lifestyle, schedule and goals, and that conversation is the right place to raise timing concerns before they become a habit of missed doses.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.